Literature DB >> 15024580

The Lubinus patellofemoral arthroplasty: a series of 17 cases.

T N Board1, A Mahmood, W G Ryan, A J Banks.   

Abstract

INTRODUCTION: The Lubinus patellofemoral arthroplasty was introduced in our institution in 1994. The first 17 patients were followed-up in order to identify the short-term outcome for this prosthesis.
MATERIALS AND METHODS: The average age at surgery was 66 years (range 37-82 years). The mean follow-up was 19 months. The indications for surgery were strictly limited to radiographically proven primary osteoarthritis affecting only the patellofemoral joint (13) and secondary arthritis due to maltracking, subluxation (3) or trauma to the patella (1). At review, the range of movement and Lysholm and Tegner scores were recorded and radiographs obtained. Patients were also asked if their outcome was satisfactory or unsatisfactory.
RESULTS: At review, only 9 (53%) knees were classified as satisfactory by the patients. Further surgery had been carried out in 6 cases (35%) including revision to total knee arthroplasty in 4 (24%). Other complications included clicking and subluxation in 3 cases (18%), extension block in 3 (18%) and infection in 1 (6%). Progression of osteoarthritis to involve other compartments occurred in 2 cases (12%).
CONCLUSIONS: Many of these early problems are related to the unforgiving nature of the prosthesis on insertion. These poor early results have led us to stop using the prosthesis.

Entities:  

Mesh:

Year:  2004        PMID: 15024580     DOI: 10.1007/s00402-004-0645-x

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  13 in total

Review 1.  Patellofemoral arthroplasty, where are we today?

Authors:  Sébastien Lustig; Robert A Magnussen; Diane L Dahm; David Parker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-10       Impact factor: 4.342

Review 2.  Patellofemoral arthroplasty: Current concepts.

Authors:  Rory Cuthbert; Saket Tibrewal; Sheo B Tibrewal
Journal:  J Clin Orthop Trauma       Date:  2017-11-22

3.  Prospective evaluation of anatomic patellofemoral inlay resurfacing: clinical, radiographic, and sports-related results after 24 months.

Authors:  Andreas B Imhoff; Matthias J Feucht; Gebhart Meidinger; Philip B Schöttle; Matthias Cotic
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-06       Impact factor: 4.342

Review 4.  Advances in Patellofemoral Arthroplasty.

Authors:  Sabrina M Strickland; Mackenzie L Bird; Alexander B Christ
Journal:  Curr Rev Musculoskelet Med       Date:  2018-06

Review 5.  Isolated patellofemoral osteoarthritis.

Authors:  Hans-Peter W van Jonbergen; Rudolf W Poolman; Albert van Kampen
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

Review 6.  Survivorship and functional outcomes of patellofemoral arthroplasty: a systematic review.

Authors:  J P van der List; H Chawla; H A Zuiderbaan; A D Pearle
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-21       Impact factor: 4.342

7.  The evaluation and management of cartilage lesions affecting the patellofemoral joint.

Authors:  Eric J Strauss; David K Galos
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

8.  A matched-pair comparison of inlay and onlay trochlear designs for patellofemoral arthroplasty: no differences in clinical outcome but less progression of osteoarthritis with inlay designs.

Authors:  Matthias J Feucht; Matthias Cotic; Knut Beitzel; Julia F Baldini; Gebhart Meidinger; Philip B Schöttle; Andreas B Imhoff
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-01       Impact factor: 4.342

9.  Surgical treatment of isolated patellofemoral osteoarthritis.

Authors:  Roland Becker; Martin Röpke; Anja Krull; Volker Musahl; Wolfgang Nebelung
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

10.  Medium term results of Avon patellofemoral joint replacement.

Authors:  Praveen K Sarda; Anup Shetty; Shanmuga S Maheswaran
Journal:  Indian J Orthop       Date:  2011-09       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.